|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 259, Issue 2 610-H618, Copyright © 1990 by American Physiological Society
ARTICLES |
K. M. Baker and J. F. Aceto
Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822.
The octapeptide [Ile5]angiotensin II (ANG II), which is the principal circulating hormone of the renin-angiotensin system, could modulate or mediate cardiac hypertrophy via indirect effects, through increases in total peripheral vascular resistance, or by direct effects on cardiac cells, which result in increased protein synthesis and cell growth. In this study we determined whether ANG II stimulated protein synthesis and cell growth in cultures of embryonic chick myocytes. After 3 h of exposure to ANG II, there were significant increases in total cellular protein at 120, 144, and 168 h and in the relative rate of protein synthesis at 120 and 144 h. There was a significant increase in the fractional rate of protein synthesis of 32.2% (0.0119 +/- 0.0008 h-1 for ANG II stimulated and 0.0090 +/- 0.0003 h-1 for control). The stimulatory effects of ANG II on protein synthesis and cell growth were inhibited by the ANG II antagonist [Sar1,Ile8]ANG II and the hexapeptide ANG II-(3-8). ANG II significantly increased total RNA levels in myocytes, at 12 h after exposure to the peptide. The stimulatory effect of ANG II (32%) on total cellular protein was slightly greater than that seen with norepinephrine (20%) in contrast to the greater stimulatory effect seen with phorbol 12,13-dibutyrate (47%). ANG II and [Sar1,Ile8]ANG II each stimulated increases in cytosolic-free Ca2+, whereas ANG II-(3-8) did not. Growth-related effects of changes in the chronotropic state of the myocytes were excluded, in that, ANG II-stimulated increases in protein synthesis and cellular protein were not inhibited by potassium chloride depolarization of the cells.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
C. Rugale, S. Delbosc, J.-P. Cristol, A. Mimran, and B. Jover Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1744 - H1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Wagner, V. Essmann, K. Mydlak, M. Wirth, G. Gmehling, J. Bohlender, H. M. Stauss, J. Gunther, I. Schimke, and H. Scholz Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R153 - R160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Satoh, F. Shirota, T. Tsunajima, C. J. Beinlich, H. E. Morgan, and K. Ichihara Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: comparison with pravastatin Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2746 - H2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsujita, N. Iwai, S. Tamaki, Y. Nakamura, M. Nishimura, and M. Kinoshita Genetic mapping of quantitative trait loci influencing left ventricular mass in rats Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2062 - H2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzolai, T. Pedrazzini, F. Nicoud, G. Gabbiani, H.-R. Brunner, and J. Nussberger Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice Hypertension, April 1, 2000; 35(4): 985 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lang, S. I. Mosfer, A. Shakesby, F. Donaldson, and M. J. Lewis Coronary Microvascular Endothelial Cell Redox State in Left Ventricular Hypertrophy : The Role of Angiotensin II Circ. Res., March 3, 2000; 86(4): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, J. W. Harding, and S. M. Simasko Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249. [Abstract] [Full Text] |
||||
![]() |
J.-H. Zhang, J. M. Hanesworth, M. F. Sardinia, J. A. Alt, J. W. Wright, and J. W. Harding Structural Analysis of Angiotensin IV Receptor (AT4) from Selected Bovine Tissues J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1075 - 1083. [Abstract] [Full Text] |
||||
![]() |
J.-H. Zhang, J. W. Stobb, J. M. Hanesworth, M. F. Sardinia, and J. W. Harding Characterization and Purification of the Bovine Adrenal Angiotensin IV Receptor (AT4) Using [125I]Benzoylphenylalanine-Angiotensin IV as a Specific Photolabel J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 416 - 424. [Abstract] [Full Text] |
||||
![]() |
K. Nakamura, K. Fushimi, H. Kouchi, K. Mihara, M. Miyazaki, T. Ohe, and M. Namba Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-{alpha} and Angiotensin II Circulation, August 25, 1998; 98(8): 794 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunisada, E. Tone, Y. Fujio, H. Matsui, K. Yamauchi-Takihara, and T. Kishimoto Activation of gp130 Transduces Hypertrophic Signals via STAT3 in Cardiac Myocytes Circulation, July 28, 1998; 98(4): 346 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzolai, J. Nussberger, J.-F. Aubert, D. B. Brunner, G. Gabbiani, H. R. Brunner, and T. Pedrazzini Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System Hypertension, June 1, 1998; 31(6): 1324 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, et al. Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice Circulation, May 19, 1998; 97(19): 1952 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakata, B. D. Hoit, S. B. Liggett, R. A. Walsh, and G. W. Dorn II Decompensation of Pressure-Overload Hypertrophy in G{alpha}q-Overexpressing Mice Circulation, April 21, 1998; 97(15): 1488 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kodama, K. Fukuda, J. Pan, S. Makino, M. Sano, T. Takahashi, S. Hori, and S. Ogawa Biphasic Activation of the JAK/STAT Pathway by Angiotensin II in Rat Cardiomyocytes Circ. Res., February 9, 1998; 82(2): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, L. T. Krebs, J. W. Harding, and S. E. Handa Angiotensin IV AT4-receptor system in the rat kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F290 - F299. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Brooks, O. H. L. Bing, K. G. Robinson, M. T. Slawsky, D. M. Chaletsky, and C. H. Conrad Effect of Angiotensin-Converting Enzyme Inhibition on Myocardial Fibrosis and Function in Hypertrophied and Failing Myocardium From the Spontaneously Hypertensive Rat Circulation, December 2, 1997; 96(11): 4002 - 4010. [Abstract] [Full Text] |
||||
![]() |
M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1824 - H1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hein, M. E. Stevens, G. S. Barsh, R. E. Pratt, B. K. Kobilka, and V. J. Dzau Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block PNAS, June 10, 1997; 94(12): 6391 - 6396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Kokkonen, J. Saarinen, and P. T. Kovanen Regulation of Local Angiotensin II Formation in the Human Heart in the Presence of Interstitial Fluid : Inhibition of Chymase by Protease Inhibitors of Interstitial Fluid and of Angiotensin-Converting Enzyme by Ang-(1-9) Formed by Heart Carboxypeptidase A–Like Activity Circulation, March 18, 1997; 95(6): 1455 - 1463. [Abstract] [Full Text] |
||||
![]() |
M. Kurabayashi and Y. Yazaki Downregulation of Angiotensin II Receptor Type 1 in Heart Failure: A Process of Adaptation or Deterioration? Circulation, March 4, 1997; 95(5): 1104 - 1107. [Full Text] |
||||
![]() |
S. Kudoh, I. Komuro, T. Mizuno, T. Yamazaki, Y. Zou, I. Shiojima, N. Takekoshi, and Y. Yazaki Angiotensin II Stimulates c-Jun NH2-Terminal Kinase in Cultured Cardiac Myocytes of Neonatal Rats Circ. Res., January 1, 1997; 80(1): 139 - 146. [Abstract] [Full Text] |
||||
![]() |
K. Kunisada, H. Hirota, Y. Fujio, H. Matsui, Y. Tani, K. Yamauchi-Takihara, and T. Kishimoto Activation of JAK-STAT and MAP Kinases by Leukemia Inhibitory Factor Through gp130 in Cardiac Myocytes Circulation, November 15, 1996; 94(10): 2626 - 2632. [Abstract] [Full Text] |
||||
![]() |
G. W. Booz and K. M. Baker Role of Type 1 and Type 2 Angiotensin Receptors in Angiotensin II–Induced Cardiomyocyte Hypertrophy Hypertension, October 1, 1996; 28(4): 635 - 640. [Abstract] [Full Text] |
||||
![]() |
H. Shimamoto and Y. Shimamoto Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance Hypertension, September 1, 1996; 28(3): 457 - 463. [Abstract] [Full Text] |
||||
![]() |
D. Susic, E. Nunez, E. D. Frohlich, and O. Prakash Angiotensin II Increases Left Ventricular Mass Without Affecting Myosin Isoform mRNAs Hypertension, August 1, 1996; 28(2): 265 - 268. [Abstract] [Full Text] |
||||
![]() |
R. L. Kent and P. J. McDermott Passive Load and Angiotensin II Evoke Differential Responses of Gene Expression and Protein Synthesis in Cardiac Myocytes Circ. Res., May 1, 1996; 78(5): 829 - 838. [Abstract] [Full Text] |
||||
![]() |
K. Lindpaintner, M. Lee, M. G. Larson, V. S. Rao, M. A. Pfeffer, J. M. Ordovas, E. J. Schaefer, A. F. Wilson, P. W.F. Wilson, R. S. Vasan, et al. Absence of Association or Genetic Linkage between the Angiotensin-Converting-Enzyme Gene and Left Ventricular Mass N. Engl. J. Med., April 18, 1996; 334(16): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Akimoto, H. Ito, M. Tanaka, S. Adachi, M. Hata, M. Lin, H. Fujisaki, F. Marumo, and M. Hiroe Heparin and Heparan Sulfate Block Angiotensin IIInduced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes : A Possible Role of Intrinsic Heparin-like Molecules in Regulation of Cardiomyocyte Hypertrophy Circulation, February 15, 1996; 93(4): 810 - 816. [Abstract] [Full Text] |
||||
![]() |
C. Lambert, Y. Massillon, and S. Meloche Upregulation of Cardiac Angiotensin II AT1 Receptors in Congenital Cardiomyopathic Hamsters Circ. Res., November 1, 1995; 77(5): 1001 - 1007. [Abstract] [Full Text] |
||||
![]() |
M. S. F. Clarke, R. W. Caldwell, H. Chiao, K. Miyake, and P. L. McNeil Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in Heart Circ. Res., June 1, 1995; 76(6): 927 - 934. [Abstract] [Full Text] |
||||
![]() |
S. Kim, K. Ohta, A. Hamaguchi, T. Yukimura, K. Miura, and H. Iwao Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats Hypertension, June 1, 1995; 25(6): 1252 - 1259. [Abstract] [Full Text] |
||||
![]() |
B. Greenberg, M. A. Quinones, C. Koilpillai, M. Limacher, D. Shindler, C. Benedict, and B. Shelton Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction : Results of the SOLVD Echocardiography Substudy Circulation, May 15, 1995; 91(10): 2573 - 2581. [Abstract] [Full Text] |
||||
![]() |
M. A. Lee, M. Bohm, S. Kim, S. Bachmann, J. Bachmann, M. Bader, and D. Ganten Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic Rat Hypertension, April 1, 1995; 25(4): 570 - 580. [Abstract] [Full Text] |
||||
![]() |
V. Regitz-Zagrosek, N. Friedel, A. Heymann, P. Bauer, M. Neuß, A. Rolfs, C. Steffen, A. Hildebrandt, R. Hetzer, and E. Fleck Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts Circulation, March 1, 1995; 91(5): 1461 - 1471. [Abstract] [Full Text] |
||||
![]() |
H. Uozumi, Y. Hiroi, Y. Zou, E. Takimoto, H. Toko, P. Niu, M. Shimoyama, Y. Yazaki, R. Nagai, and I. Komuro gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy J. Biol. Chem., June 15, 2001; 276(25): 23115 - 23119. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |